Serious fungal infections in Korea

Original Article
Part of the following topical collections:
  1. Global Fungal Disease Burden

Abstract

Information on the incidence and prevalence of fungal infections is of critical value in public health policy. However, nationwide epidemiological data on fungal infections are scarce, due to a lack of surveillance and funding. The objective of this study was to estimate the disease burden of fungal infections in the Republic of Korea. An actuarial approach using a deterministic model was used for the estimation. Data on the number of populations at risk and the frequencies of fungal infections in those populations were obtained from national statistics reports and epidemiology papers. Approximately 1 million people were estimated to be affected by fungal infections every year. The burdens of candidemia (4.12 per 100,000), cryptococcal meningitis (0.09 per 100,000), and Pneumocystis pneumonia (0.51 per 100,000) in South Korea were estimated to be comparable to those in other countries. The prevalence of chronic pulmonary aspergillosis (22.4 per 100,000) was markedly high, probably due to the high burden of tuberculosis in Korea. The low burdens of allergic bronchopulmonary aspergillosis (56.9 per 100,000) and severe asthma with fungal sensitization (75.1 per 100,000) warrant further study. Oral candidiasis (539 per 100,000) was estimated to affect a much larger population than noted in previous studies. Our work provides valuable insight on the epidemiology of fungal infections; however, additional studies are needed.

Notes

Compliance with ethical standards

Funding

No funding was provided for this research.

Conflict of interest

All authors report nothing to declare.

References

  1. 1.
    Brown GD, Denning DW, Gow NA et al (2012) Hidden killers: human fungal infections. Sci Transl Med 4:165rv13CrossRefPubMedGoogle Scholar
  2. 2.
    Global Action Fund for Fungal Infections (GAFFI). Academic Papers. Available online at: http://www.gaffi.org/media/academic-papers/. Accessed 14 Nov 2016
  3. 3.
    Statistics Korea (2010) Population Census 2010. Available online at: http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A#SubCont. Accessed 18 Dec 2015
  4. 4.
    Korea Centers for Disease Control and Prevention (KCDC) (August 2014) Annual Report on the Notified HIV/AIDS in Korea. Osong, Republic of KoreaGoogle Scholar
  5. 5.
    Korea Centers for Disease Control and Prevention (KCDC) (2013) Annual Report on the Notified Tuberculosis in Korea, 2012. Osong, Republic of KoreaGoogle Scholar
  6. 6.
    World Health Organization (WHO). Antiretroviral therapy coverage. Data and estimates by country. Available online at: http://apps.who.int/gho/data/view.main.23300. Accessed 11 Dec 2015
  7. 7.
    Park HJ, Park EH, Jung KW et al (2012) Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol 47:28–38CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kim J-M, Ko Y-H, Lee S-S et al (2011) WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol 45:254–260CrossRefGoogle Scholar
  9. 9.
    Korean Network for Organ Sharing (KONOS) (2011) Annual Report of the Transplant 2011. Seoul, KoreaGoogle Scholar
  10. 10.
    Yoo KH, Kim YS, Sheen SS et al (2011) Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 16:659–665CrossRefPubMedGoogle Scholar
  11. 11.
    Kim C-Y, Park H-W, Ko S-K et al (2011) The financial burden of asthma: a nationwide comprehensive survey conducted in the Republic of Korea. Allergy Asthma Immunol Res 3:34–38CrossRefPubMedGoogle Scholar
  12. 12.
    Kim JM, Cho GJ, Hong SK et al (2003) Epidemiology and clinical features of HIV infection/AIDS in Korea. Yonsei Med J 44:363–370CrossRefPubMedGoogle Scholar
  13. 13.
    Kim SH, Kee SY, Lee DG et al (2013) Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens. Transpl Infect Dis 15:49–59CrossRefPubMedGoogle Scholar
  14. 14.
    Kim T, Choi SH, Kim SH et al (2013) Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol 92:231–238CrossRefPubMedGoogle Scholar
  15. 15.
    Choi YI, Hwang S, Park GC et al (2013) Clinical outcomes of Pneumocystis carinii pneumonia in adult liver transplant recipients. Transplant Proc 45:3057–3060CrossRefPubMedGoogle Scholar
  16. 16.
    Jeong SJ, Chae YT, Jin SJ et al (2010) Cryptococcal meningitis: 12 years experience in a single tertiary health care center. Infect Chemother 42:285–290CrossRefGoogle Scholar
  17. 17.
    Yun JH, Lee SO, Jo KW et al (2015) Infections after lung transplantation: time of occurrence, sites, and microbiologic etiologies. Korean J Intern Med 30:506–514CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ju MK, Joo DJ, Kim SJ et al (2009) Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience. Transplant Proc 41:375–378CrossRefPubMedGoogle Scholar
  19. 19.
    Ruhnke M, Groll AH, Mayser P et al (2015) Estimated burden of fungal infections in Germany. Mycoses 58(Suppl 5):22–28CrossRefPubMedGoogle Scholar
  20. 20.
    Kwon J-C, Kim S-H, Park SH et al (2012) Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea. Tuberc Respir Dis (Seoul) 72:284–292CrossRefGoogle Scholar
  21. 21.
    Guinea J, Torres-Narbona M, Gijón P et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870–877CrossRefPubMedGoogle Scholar
  22. 22.
    Denning DW, Pleuvry A, Cole DC (2011) Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 89:864–872CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Takeda K, Imamura Y, Takazono T et al (2016) The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol 54:120–127CrossRefPubMedGoogle Scholar
  24. 24.
    Ide S, Nakamura S, Yamamoto Y et al (2015) Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan. PLoS One 10, e0128304CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Namkoong H, Kurashima A, Morimoto K et al (2016) Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis 22:1116–1117CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Nam HS, Jeon K, Um SW et al (2010) Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 14:e479–e482CrossRefPubMedGoogle Scholar
  27. 27.
    Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370CrossRefPubMedGoogle Scholar
  28. 28.
    Xhaard A, Lanternier F, Porcher R et al (2012) Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003–2008). Clin Microbiol Infect 18:E396–E400CrossRefPubMedGoogle Scholar
  29. 29.
    Pappas PG, Alexander BD, Andes DR et al (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50:1101–1111CrossRefPubMedGoogle Scholar
  30. 30.
    Jeon MH, Kim TH, Kim SR et al (2015) Korean nosocomial infections surveillance system, intensive care unit module report: data summary from July 2012 through June 2013. Korean J Nosocomial Infect Control 20:37–48CrossRefGoogle Scholar
  31. 31.
    Tan BH, Chakrabarti A, Li RY et al (2015) Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21:946–953CrossRefPubMedGoogle Scholar
  32. 32.
    Montravers P, Mira JP, Gangneux JP et al (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17:1061–1067CrossRefPubMedGoogle Scholar
  33. 33.
    Jung SI, Shin JH, Choi HJ et al (2012) Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea. Ann Lab Med 32:426–428CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ha YE, Peck KR, Joo EJ et al (2012) Impact of first-line antifungal agents on the outcomes and costs of candidemia. Antimicrob Agents Chemother 56:3950–3956CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Shiboski CH, Chen H, Secours R et al (2015) High accuracy of common HIV-related oral disease diagnoses by non-oral health specialists in the AIDS Clinical Trial Croup. PLoS One 10, e0131001Google Scholar
  36. 36.
    Lalla RV, Latortue MC, Hong CH et al (2010) A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18:985–992CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Smith E, Orholm M (1990) Trends and patterns of opportunistic diseases in Danish AIDS patients 1980–1990. Scand J Infect Dis 22:665–672CrossRefPubMedGoogle Scholar
  38. 38.
    Choi JH, Lee CG, Lim YJ et al (2013) Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei Med J 54:160–165CrossRefPubMedGoogle Scholar
  39. 39.
    Foxman B, Muraglia R, Dietz JP et al (2013) Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17:340–345CrossRefPubMedGoogle Scholar
  40. 40.
    Nielsen SE, Nielsen E, Julian HO et al (2015) Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol 93:54–58CrossRefPubMedGoogle Scholar
  41. 41.
    Lee JH, Chung HJ, Lee KH (2002) A clinical and mycological study on dermatophytoses in children. Korean J Med Mycol 7:209–216Google Scholar
  42. 42.
    Kim S-H, Cho S-H, Youn S-K et al (2015) Epidemiological characterization of skin fungal infections between the years 2006 and 2010 in Korea. Osong Public Health Res Perspect 6:341–345CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Park JS, Cho SH, Youn SK et al (2016) Epidemiological characterization of opportunistic mycoses between the years 2006 and 2010 in Korea. J Microbiol Biotechnol 26:145–150CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • K. Huh
    • 1
    • 2
  • Y. E. Ha
    • 1
  • D. W. Denning
    • 3
    • 4
    • 5
  • K. R. Peck
    • 1
  1. 1.Division of Infectious Diseases, Department of Medicine, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulKorea
  2. 2.Division of Infectious DiseasesArmed Forces Capital HospitalSeongnamKorea
  3. 3.The National Aspergillosis CentreUniversity Hospital of South ManchesterManchesterUK
  4. 4.The University of ManchesterManchesterUK
  5. 5.Manchester Academic Health Science CentreManchesterUK

Personalised recommendations